Project: We benchmarked whether Boltz-2 (an AlphaFold-class structure predictor) can substitute for a binding measurement, testing two complementary questions across two systems: does its confidence score rank affinity (SH2 domains vs. measured KD panels for c-Src and Fyn), and does it detect a damaged interface (MDM2:PMI under site-saturation mutagenesis). What we found: Boltz-2 reliably separates binders from non-binders — free two-peptide competition is the best readout (65% c-Src, 81% Fyn) — and maps which residues matter with anchor-localized, chemically-coherent sensitivity. But it cannot resolve fine affinity rank among true binders (the Fyn 1-log test collapses, residual pointing the wrong way), and the peptide-linker fusion trick does not transfer to a folded protein–protein interface (barnase–barstar fails at every linker length, even femtomolar wild-type). Why it matters: It draws a clear, evidence-backed boundary for using structure-prediction confidence as an affinity proxy — sound for binder/non-binder triage and interface-hotspot reading, unreliable for quantitative ranking — so users know which question the score can actually answer before they trust it.
More from Built with Claude: Life Sciences
What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…
About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…
